Status:
RECRUITING
Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
COPD
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In our study, changes in vastus lateralis muscle oxygenation will be evaluated with the Moxy device, a functional infrared oxygen measurement device, during the inspiratory muscle fatigue protocol in ...
Eligibility Criteria
Inclusion
- Having a diagnosis of Stage 2-3 COPD according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).
- Having been using the same medications for the last 4 weeks
Exclusion
- Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min).
- Presence of any vascular problem that may affect lower extremity muscle oxygenation
- Presence of another respiratory system disease other than COPD
- Patients who have had an acute COPD exacerbation in the last 4 weeks
- Patients experiencing COPD exacerbations during the study protocol
- Presence of fatty tissue or scar tissue at the measurement points, which may impair the measurement quality.
- Have already participated in another clinical trial within the last 30 days that may affect the results of the study.
- Inclusion Criteria for Healthy Cases
- Being over 18 years of age
- Not having any diagnosed chronic disease
- Not being a smoker
Key Trial Info
Start Date :
January 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06217276
Start Date
January 20 2024
End Date
January 15 2026
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye), 34200